145 related articles for article (PubMed ID: 9511938)
1. CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma.
Ruiz P; Mailhot S; Delgado P; Amador A; Viciana AL; Ferrer L; Zacharievich N
Cytometry; 1998 Feb; 34(1):30-5. PubMed ID: 9511938
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.
Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J
Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038
[TBL] [Abstract][Full Text] [Related]
3. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India.
Patkar N; Nair S; Alex AA; Parihar M; Manipadam MT; Arora N; Ahmed R; Abraham A; George B; Viswabandya A; Srivastava V; Srivastava A; Mathews V
Leuk Lymphoma; 2012 Apr; 53(4):609-15. PubMed ID: 21916832
[TBL] [Abstract][Full Text] [Related]
5. Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny.
Ruiz P; Zacharievich N; Hao L; Viciana AL; Shenkin M
Clin Immunol Immunopathol; 1998 Aug; 88(2):156-68. PubMed ID: 9714693
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
7. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
[TBL] [Abstract][Full Text] [Related]
8. [A case of hepatosplenic gammadelta T cell lymphoma].
Wang FX; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
[TBL] [Abstract][Full Text] [Related]
9. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.
Macon WR; Levy NB; Kurtin PJ; Salhany KE; Elkhalifa MY; Casey TT; Craig FE; Vnencak-Jones CL; Gulley ML; Park JP; Cousar JB
Am J Surg Pathol; 2001 Mar; 25(3):285-96. PubMed ID: 11224598
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic αβ T-cell lymphoma with myelodysplastic syndrome.
Takaku T; Miyazawa K; Sashida G; Shoji N; Shimamoto T; Yamaguchi N; Ito Y; Nakamura S; Mukai K; Ohyashiki K
Int J Hematol; 2005 Aug; 82(2):143-7. PubMed ID: 16146847
[TBL] [Abstract][Full Text] [Related]
15. CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry.
Klobusická M; Babusíková O
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():34-7. PubMed ID: 10707830
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD26 and DPP IV in T-acute lymphoblastic leukemia: comparison of immunocytochemistry with enzyme cytochemistry.
Klobusická M; Babusíková O
Neoplasma; 1999; 46(5):299-303. PubMed ID: 10665846
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic gamma delta T-cell lymphoma--not just alphabet soup.
Chang KL; Arber DA
Adv Anat Pathol; 1998 Jan; 5(1):21-9. PubMed ID: 9868510
[No Abstract] [Full Text] [Related]
19. Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution.
Detel D; Buljevic S; Pucar LB; Kucic N; Pugel EP; Varljen J
J Physiol Biochem; 2016 Sep; 72(3):405-19. PubMed ID: 27125676
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
